Moneycontrol PRO
HomeNewsOpinionChart of the Day: Focus on fewer products in the US is yielding good results for Indian pharma

Chart of the Day: Focus on fewer products in the US is yielding good results for Indian pharma

Companies sought fewer approvals for generic drugs in 2023 even as they stepped up focus on complex products

May 14, 2024 / 08:12 IST
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts